Sign in

CIK 0000887359 · Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
operating
EIN
943096597
Phone
6175885555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,787,802
in 7 filings, $5.8M under 10b5-1 plans

Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Sale −4,375 $17.37 $76K 122,672
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise +9,375 $2.65 $25K 132,047
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Sale −9,375 $17.74 $166K 122,672
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise +1,875 $7.20 $14K 124,547
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Sale −1,875 $17.74 $33K 122,672
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise · Stock Option (right to buy) −4,375 65,625
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise · Stock Option (right to buy) −9,375 15,000
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise · Stock Option (right to buy) −1,875 98,125
2019-03-11 MICHEL GERARD J CFO and VP, Corp. Development Sale −10,000 $20.02 $200K 122,249
2019-02-28 GILMAN STEVEN C Director Option exercise +7,500 $2.76 $21K 7,500
2019-02-28 GILMAN STEVEN C Director Sale −7,500 $18.02 $135K 0
2019-02-28 GILMAN STEVEN C Director Option exercise · Stock Option (right to buy) −7,500 7,500
2019-02-15 Colangelo Dominick President and CEO Option exercise +27,500 $3.02 $83K 102,663
2019-02-15 Colangelo Dominick President and CEO Option exercise +8,692 $1.95 $17K 111,355
2019-02-15 Colangelo Dominick President and CEO Option exercise · Stock Option (right to buy) −27,500 383,452
2019-02-15 Colangelo Dominick President and CEO Option exercise · Stock Option (right to buy) −8,692 63,496
2019-02-11 MICHEL GERARD J CFO and VP, Corp. Development Sale −10,000 $17.09 $171K 132,249
2019-02-06 Orlando Daniel Chief Operating Officer Grant or award · Stock Option (right to buy) +130,697 130,697
2019-02-06 Orlando Daniel Chief Operating Officer Grant or award · Stock Option (right to buy) +9,303 9,303
2019-02-06 Orlando Daniel Chief Operating Officer Grant or award · Restricted Stock Unit +14,000 14,000

Page 60 of 75 · 1,497 trades